<DOC>
	<DOCNO>NCT02208791</DOCNO>
	<brief_summary>The purpose study determine effect sirolimus phenotype peripheral blood T B lymphocytes regard na√Øve , memory , effector end regulatory phenotype development anti-HLA antibody among kidney transplant recipient high immunological risk graft rejection .</brief_summary>
	<brief_title>Effects Quadruple Immunosuppression Peripheral Blood Lymphocytes Development Anti-HLA Antibodies Kidney Transplant</brief_title>
	<detailed_description />
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Men woman , age 18 60 year inclusive Percentage Panel Reactive Antibodies transplantation &gt; 20 % Estimated glomerular filtration rate use MDRD formula inclusion &gt; 29ml/min Subjects history cancer Subjects previous non kidney transplantation Subjects receive immunosuppression different tacrolimus/prednisone/mycophenolate Subjects urinary protein/creatinine ratio great 0.3 Subjects active HBV , HCV HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Kidney Transplantation</keyword>
	<keyword>Graft Rejection</keyword>
	<keyword>Immunossupression</keyword>
</DOC>